CLINICAL_TRIALS
trial_result
· 2015-05-12
Clinical Trial Update: A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride [Phase 2]
Summary
Phase 2 dose-response trial of midodrine hydrochloride at 5 mg and 10 mg for orthostatic hypotension, including individuals with spinal cord injury; results wer…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: James J. Peters Veterans Affairs Medical Center | Conditions: Orthostatic Hypotension, Spinal Cord Injury | Phase 2 | Status: COMPLETED | Results posted: 2015-05-12